- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/31 - Chimeric antigen receptors [CAR]
Patent holdings for IPC class A61K 40/31
Total number of patents in this class: 308
10-year publication summary
|
2
|
1
|
1
|
4
|
10
|
9
|
13
|
6
|
6
|
204
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4308 |
11 |
| Janssen Biotech, Inc. | 1531 |
10 |
| The Regents of the University of California | 19812 |
9 |
| Juno Therapeutics, Inc. | 383 |
8 |
| City of Hope | 979 |
6 |
| Kite Pharma, Inc. | 408 |
6 |
| Allogene Therapeutics, Inc. | 152 |
6 |
| The General Hospital Corporation | 4704 |
5 |
| Memorial Sloan-Kettering Cancer Center | 1910 |
5 |
| Sloan-Kettering Institute for Cancer Research | 508 |
4 |
| Memorial Hospital for Cancer and Allied Diseases | 281 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6365 |
3 |
| Duke University | 3058 |
3 |
| Autolus Limited | 251 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2553 |
3 |
| Musc Foundation for Research Development | 348 |
3 |
| Regeneron Pharmaceuticals, Inc. | 4223 |
3 |
| Seattle Children's Hospital (dba Seattle Children's Research Institute) | 182 |
3 |
| A2 Biotherapeutics, Inc. | 82 |
3 |
| Miltenyi Biotec B.V. & Co. KG | 346 |
3 |
| Other owners | 207 |